Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
With a focus on individualized support, SkinnyRx ensures each client receives the attention and expertise needed to achieve their personal health objectives, fostering a community of empowered and healthier individuals.
Approximately 15-20% of trial participants across both medications achieved what researchers term super-responder status, exceeding 30% weight loss
ABLC screens for factors such as pregnancy, breastfeeding, thyroid cancer history, severe gastrointestinal conditions, allergies to GLP-1 medications, and other health considerations before treatment
In the SURMOUNT-1 trial, participants on the highest dose lost an average of 22.4% of their body weight at 72 weeks numbers that approach what bariatric surgery achieves
